Adial Pharmaceuticals, Inc. (ADIL)
NASDAQ: ADIL · Real-Time Price · USD
0.3701
-0.0113 (-2.96%)
At close: Oct 13, 2025, 4:00 PM EDT
0.3701
0.00 (0.00%)
Pre-market: Oct 14, 2025, 5:51 AM EDT
Adial Pharmaceuticals Market Cap
Adial Pharmaceuticals has a market cap or net worth of $8.08 million as of October 14, 2025. Its market cap has increased by 21.31% in one year.
Market Cap
8.08M
Enterprise Value
2.16M
1-Year Change
21.31%
Ranking
Category
Stock Price
$0.37
Market Cap Chart
Since July 30, 2018, Adial Pharmaceuticals's market cap has decreased from $26.34M to $8.08M, a decrease of -69.32%. That is a compound annual growth rate of -15.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 8.33M | 27.31% |
| Dec 31, 2024 | 6.54M | 188.66% |
| Dec 29, 2023 | 2.27M | -60.76% |
| Dec 30, 2022 | 5.77M | -89.79% |
| Dec 31, 2021 | 56.56M | 131.14% |
| Dec 31, 2020 | 24.47M | -1.60% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 30, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 735.60B |
| Johnson & Johnson | 459.75B |
| AbbVie | 406.84B |
| UnitedHealth Group | 324.83B |
| AstraZeneca | 263.00B |
| Novo Nordisk | 257.10B |
| Novartis AG | 251.30B |
| Abbott Laboratories | 228.66B |